Dr. Ann Taylor is a physician with more than 35 years of experience in understanding human disease and the evaluation and testing of new medicines. Ann served as Chief Medical Officer at AstraZeneca from 2019-2021. In this role, she was responsible for AstraZeneca’s Patient Safety, Quality Assurance, and Regulatory Policy organizations, and the overall Benefit Risk assessment of our medicines. She is passionate about bringing the patient voice to everything she does and has a particular interest in health equity—knowing that access to nature is an important factor that contributes to multiple social determinants of health. Prior to joining AstraZeneca in 2018, Ann was Vice President and Global Head of the Program Office for the Novartis Institutes for BioMedical Research (NIBR). She also previously served as Global Head, Translational Medicine at NIBR, after having positions of increasing responsibility at Pfizer Global Research and Development.
Ann received her M.D. from Harvard Medical School, after receiving her B.A. in Biology magna cum laude from the University of California, San Diego. She completed her internship and residency in Internal Medicine, and her fellowship in Endocrinology and Metabolism at Massachusetts General Hospital, before joining the faculty there. She has published over 45 journal articles.
In addition to TPL, Ann also serves on the board of Yleana Leadership Foundation which is improving the racial wealth gap by getting underserved kids into better colleges, with better financial aid packages, higher graduation rates, and better paying jobs. She also serves as Chair of the Nominating Committee: of Women in Endocrinology, The Endocrine Society as well as Co-Chair of the National Academies of Science, Engineering and Medicine Forum on Drug Discovery, Development, and Translation.
Ann lives in Wickford, Rhode Island with her husband Kevin. She has had a cabin in Raymond ME for almost 25 years. In her free time, she enjoys hiking, traveling, gardening, birding, and food.